Devyser Diagnostics (Sweden) Today
| DVYSR Stock | 130.00 2.00 1.52% |
Performance8 of 100
| Odds Of DistressLess than 31
|
Devyser Diagnostics is selling for under 130.00 as of the 30th of November 2024; that is 1.52 percent decrease since the beginning of the trading day. The stock's lowest day price was 128.0. Devyser Diagnostics has about a 31 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Devyser Diagnostics AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
Moving together with Devyser Stock
Moving against Devyser Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Devyser Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Devyser Diagnostics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Devyser Diagnostics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Diagnostics & Research, Healthcare (View all Sectors) |
Devyser Diagnostics AB (DVYSR) is traded on Stockholm Exchange in Sweden and employs 87 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Devyser Diagnostics's market, we take the total number of its shares issued and multiply it by Devyser Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Devyser Diagnostics operates under Healthcare sector and is part of Diagnostics & Research industry. The entity has 16.01 M outstanding shares.
Check Devyser Diagnostics Probability Of Bankruptcy
Ownership AllocationDevyser Diagnostics holds a total of 16.01 Million outstanding shares. Devyser Diagnostics AB shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.12 percent of Devyser Diagnostics outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Also note that almost three hundred fourty thousand nine hundred thirty-six invesors are currently shorting Devyser Diagnostics expressing very little confidence in its future performance.
Check Devyser Ownership Details
Devyser Diagnostics Risk Profiles
Although Devyser Diagnostics' alpha and beta are two of the key measurements used to evaluate Devyser Diagnostics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.7 | |||
| Semi Deviation | 1.78 | |||
| Standard Deviation | 2.35 | |||
| Variance | 5.51 |
Devyser Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Devyser Diagnostics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Devyser Diagnostics Corporate Management
Elected by the shareholders, the Devyser Diagnostics' board of directors comprises two types of representatives: Devyser Diagnostics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Devyser. The board's role is to monitor Devyser Diagnostics' management team and ensure that shareholders' interests are well served. Devyser Diagnostics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Devyser Diagnostics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Theis Kipling | Chief Officer | Profile | |
| Ulf Klangby | Founder CEO | Profile | |
| Camilla Wiberg | Chief Officer | Profile | |
| John Murad | VP US | Profile | |
| Sabina Berlin | Chief Officer | Profile | |
| Fredrik Alpsten | Chief Officer | Profile | |
| Goran Rydin | Chief Officer | Profile |
Additional Tools for Devyser Stock Analysis
When running Devyser Diagnostics' price analysis, check to measure Devyser Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devyser Diagnostics is operating at the current time. Most of Devyser Diagnostics' value examination focuses on studying past and present price action to predict the probability of Devyser Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devyser Diagnostics' price. Additionally, you may evaluate how the addition of Devyser Diagnostics to your portfolios can decrease your overall portfolio volatility.